Clinical trial
Sb-705498 Rectal Pain Study
NCT00461682 · GlaxoSmithKline, Industry · Terminated
Key facts
| NCT number | NCT00461682 |
|---|---|
| Title | Sb-705498 Rectal Pain Study |
| Official title | A Double-blind, Randomised, Placebo Controlled, Single Dose, Two-period Crossover Study to Investigate the Therapeutic Potential of the TRPV1 Antagonist SB-705498 in Treatment of Subjects With Rectal Hypersensitivity Including Irritable Bowel Syndrome. |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Irritable Colon |
| Intervention type | Drug |
| Interventions | SB-705498 |
| Enrollment | 1 |
| Start date | Jan 26, 2007 |
| Primary completion | Sep 1, 2007 |
| Completion | Sep 1, 2007 |
| First posted | Apr 18, 2007 |
| Last update posted | Aug 20, 2018 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: